- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00602732
Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse
Intervention for Low-income Pregnant Women With Partner Abuse
Visão geral do estudo
Status
Condições
Descrição detalhada
Each year, approximately 324,000 pregnant women experience partner abuse (PA). With the emotional highs and lows that accompany new motherhood, pregnancy is often a challenging process for many women. Experiencing PA, while already going through a vulnerable time during pregnancy, may have harmful effects on the well-being of the woman and her infant. Women affected by PA are at an increased risk for certain physical and psychological problems, including depression and post-traumatic stress disorder (PTSD). Furthermore, the emotional distress from PA may impair a woman's ability to seek out the necessary support to ensure the safety of herself and her children. There have been few research efforts to develop an effective treatment to reduce the psychological impact of PA on pregnant women and even fewer efforts that target low-income women, who make up a large portion of affected women. The Reach Out for a Safe Environment (ROSE) program is an interpersonally oriented treatment developed to address factors that may contribute to postpartum mental health difficulties associated with PA. This study will evaluate the effectiveness of the ROSE program in preventing depression and PTSD in low-income pregnant women who have experienced recent PA.
Participation in this single-blind study will last approximately 29 weeks. All potential participants will answer an initial questionnaire concerning their history of physical, sexual, or emotional abuse in the past year. Selected participants will then undergo an interview about symptoms of depression, reactions to trauma, emotional difficulties, and alcohol and drug use. Participants invited to continue in the study will then be randomly assigned to the ROSE program or enhanced care as usual (ECU). Participants assigned to the ROSE program will attend four weekly 90-minute group sessions prior to delivery and one individual 50-minute booster session within 4 weeks of delivery. During these sessions, participants will learn ways to manage stress and negative feelings and how to access helpful resources. Participants will also complete two questionnaires about emotional difficulties per week for the duration of the program. Participants assigned to ECU will receive the usual medical care provided for pregnant women and will receive educational material on depression.
All participants will complete questionnaires and interviews about their emotional difficulties, relationships with others, and use of services for these difficulties prior to treatment assignment, 4 weeks after treatment assignment, 4 weeks after delivery, and 3 months after delivery. Participants in the ROSE program will additionally complete a questionnaire about their perceptions of the program after the fourth treatment session and after the booster session.
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 1
Contactos e Locais
Locais de estudo
-
-
Rhode Island
-
Providence, Rhode Island, Estados Unidos, 02905
- Memorial Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Able to speak and read English sufficiently to complete the study procedures
- Willing and able to receive public assistance
- Identified as having experienced physical assault based on responses to CTS2 within 1 year prior to study entry
- 35 weeks or less gestation
Exclusion Criteria:
- Meets current criteria for major depressive disorder or post-traumatic stress disorder
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: 1
Participants assigned to the ROSE program
|
Participants in the ROSE program will receive a course on managing stress and negative feelings and will learn how to access resources for help.
The ROSE program involves four 90-minute group sessions over a 4-week period prior to delivery.
Participants will also attend one 50-minute booster session within 4 weeks prior to delivery of their babies.
Outros nomes:
|
|
Comparador Ativo: 2
Participants assigned to enhanced care as usual
|
Participants in ECU will receive the usual medical care provided for pregnant women at their prenatal clinic.
Participants will also receive educational material and a list of treatment resources for depression.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
Longitudinal Interval Follow-up Examination (LIFE)
Prazo: Measured at Year 1
|
Measured at Year 1
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
Revised Conflict Tactic Scale (CTS2)
Prazo: Measured at Year 1
|
Measured at Year 1
|
|
Edinburgh Postnatal Depression Scale
Prazo: Measured at Year 1
|
Measured at Year 1
|
|
The Davidson Trauma Scale
Prazo: Measured at Year 1
|
Measured at Year 1
|
|
The Arizona Social Support Interview Schedule
Prazo: Measured at Year 1
|
Measured at Year 1
|
|
Parenting Stress Index
Prazo: Measured at Year 1
|
Measured at Year 1
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Caron Zlotnick, PhD, Butler Hospital
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- R34MH075013 (Concessão/Contrato do NIH dos EUA)
- DSIR 83-ATP (NCT00719979)
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .